2023-08-10
Why is the mouse model prioritized as the preferred animal model for gene therapy research?
In this issue, we invited Mr. Han Lanqing, Director of the Artificial Intelligence Innovation Center of Tsinghua Pearl River Research Institute and Executive Secretary-General of the Guangzhou Rare Disease Gene Therapy Alliance.
2023-08-10
When it comes to the diagnosis and treatment of rare diseases, if the disease-causing locus cannot be found, how should we analyze and study it?
For rare disease diagnosis and treatment, the problem of not being able to locate the disease-causing locus is very challenging. Is there a fast and accurate solution available?
For rare disease diagnosis and treatment, the problem of not being able to locate the disease-c
2023-08-10
The use of AI neural networks can help advance the development of gene therapy drugs
Mr. Han Lanqing, Director of the AI Innovation Center of Tsinghua Pearl River Research Institute and Executive Secretary-General of the Guangzhou Rare Disease Gene Therapy Alliance, stated that from the perspective of AI synthetic biology and directed evolution, better vectors may be discovered to assist in the development of gene therapy drugs for rare diseases. Click on the video to follow Mr. Han's introduction and learn more about this topic.